Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Riboside in Systolic Heart Failure
NCT03423342Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide riboside, sponsored by University of Washington. Started May 2016; status: completed.
02
Drugs
nicotinamide riboside
Beyond the preview
Go deeper on NCT03423342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423342.